A Systematic Review of Procedural Complications from Transforaminal Lumbar Puncture for Intrathecal Nusinersen Administration in Patients with Spinal Muscular Atrophy

References

1. 1.↵
   1. Lunn MR,
   2. Wang CH

   . Spinal muscular atrophy. Lancet 2008;371:2120–33 doi:10.1016/S0140-6736(08)60921-6 pmid:18572081

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Stolte B,
   2. Totzeck A,
   3. Kizina K, et al

   . Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy. Ther Adv Neurol Disord 2018;11:1756286418803246 doi:10.1177/1756286418803246 pmid:30305849

   CrossRefPubMed
3. 3.↵
   1. Filippiadis DK,
   2. Binkert C,
   3. Pellerin O, et al

   . CIRSE quality assurance document and standards for classification of complications: the CIRSE classification system. Cardiovasc Intervent Radiol 2017;40:1141–6 doi:10.1007/s00270-017-1703-4 pmid:28584945

   CrossRefPubMed
4. 4.↵
   1. Mousa MA,
   2. Aria DJ,
   3. Schaefer CM, et al

   . A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy. Pediatr Radiology 2018;48:1797–805 doi:10.1007/s00247-018-4206-9 pmid:30022258

   CrossRefPubMed
5. 5.↵
   1. Nascene DR,
   2. Ozutemiz C,
   3. Estby H, et al

   . Transforaminal lumbar puncture: an alternative technique in patients with challenging access. AJNR Am J Neuroradiol 2018;39:986–91 doi:10.3174/ajnr.A5596 pmid:29567652

   Abstract/FREE Full Text
6. 6.↵
   1. Geraci AP,
   2. Black K,
   3. Jin M, et al

   . Transforaminal lumbar puncture for intrathecal nusinersen administration. Muscle Nerve 2018 Jan 24 [Epub ahead of print] doi:10.1002/mus.26082

   CrossRefPubMed
7. 7.↵
   1. Bortolani S,
   2. Stura G,
   3. Ventilii G, et al

   . Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: transforaminal versus conventional approach. Neuromuscul Disord 2019;29:742–46 doi:10.1016/j.nmd.2019.08.007 pmid:31604650

   CrossRefPubMed
8. 8.↵
   1. Towbin R,
   2. Schaefer C,
   3. Kaye R, et al

   . The complex spine in children with spinal muscular atrophy: the transforaminal approach - a transformative technique. AJNR Am J Neuroradiol 2019;40:1422–26 doi:10.3174/ajnr.A6131 pmid:31296522

   Abstract/FREE Full Text
9. 9.↵
   1. Velayudhan V,
   2. Patel S,
   3. Danziger A, et al

   . Transforaminal lumbar puncture for intrathecal access: case series with literature review and comparison to other techniques. J Clin Neurosci 2020;72:114–18 doi:10.1016/j.jocn.2019.12.056 pmid:31980274

   CrossRefPubMed
10. 10.↵
    1. Cartwright MS,
    2. Ward ZT,
    3. White EP, et al

    . Intrathecal delivery of nusinersen in individuals with complicated spines. Muscle and Nerve 2020;62:114–18 doi:10.1002/mus.26899 pmid:32319101

    CrossRefPubMed
11. 11.↵
    1. Weaver JJ,
    2. Hallam DK,
    3. Chick JFB, et al

    . Transforaminal intrathecal delivery of nusinersen for older children and adults with spinal muscular atrophy and complex spinal anatomy: an analysis of 200 consecutive injections. J Neurointerv Surg 2021;13:75–78 doi:10.1136/neurintsurg-2020-016058 pmid:32471828

    Abstract/FREE Full Text
12. 12.↵
    1. Shokuhfar T,
    2. Abdalla RN,
    3. Hurley MC, et al

    . Transforaminal intrathecal access for injection of nusinersen in adult and pediatric patients with spinal muscular atrophy. J Pediatr Neurol 2020;18:88–94 doi:10.1055/s-0039-1697583

    CrossRef
13. 13.↵
    1. Jacobson JP,
    2. Cristiano BC,
    3. Hoss DR

    . Simple fluoroscopy-guided transforaminal lumbar puncture: safety and effectiveness of a coaxial curved-needle technique in patients with spinal muscular atrophy and complex spines. AJNR Am J Neuroradiol 2020;41:183–88 doi:10.3174/ajnr.A6351 pmid:31831464

    Abstract/FREE Full Text
14. 14.↵
    1. Özütemiz C,
    2. Karachunski P,
    3. Nascene D.R

    . Nusinersen injections in adults and children with spinal muscular atrophy: a single-center experience. Diagn Interv Radiol 2020;26:596–602 doi:10.5152/dir.2020.19607 pmid:32436843

    CrossRefPubMed
15. 15.↵
    1. Spiliopoulos S,
    2. Reppas L,
    3. Zompola C, et al

    . Computed-tomography-guided transforaminal intrathecal nusinersen injection in adults with spinal muscular atrophy type 2 and severe spinal deformity: feasibility, safety and radiation exposure considerations. Eur J Neurol 2020;27:1343–49 doi:10.1111/ene.14245

    CrossRef
16. 16.↵
    1. Cordts I,
    2. Lingor P,
    3. Friedrich B, et al

    . Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy. Ther Adv Neurol Disord 2020;13:1756286419887616 doi:10.1177/1756286419887616 pmid:32010224

    CrossRefPubMed
17. 17.↵
    1. Claborn MK,
    2. Stevens DL,
    3. Walker CK, et al

    . Nusinersen: a treatment for spinal muscular atrophy. Ann Pharmacother 2019;53:61–69 doi:10.1177/1060028018789956 pmid:30008228

    CrossRefPubMed
18. 18.↵
    1. Veerapandiyan A,
    2. Pal R,
    3. D’Ambrosio S, et al

    . Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy. Neurology 2018;91:e620–24 doi:10.1212/WNL.0000000000006006 pmid:30006410

    CrossRefPubMed
19. 19.↵
    1. Ortiz CB,
    2. Kukreja KU,
    3. Lotze TE, et al

    . Ultrasound-guided cervical puncture for nusinersen administration in adolescents. Pediatr Radiol 2019;49:136–40 doi:10.1007/s00247-018-4240-7 pmid:30167764

    CrossRefPubMed